Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000729984 | SCV000857690 | uncertain significance | not provided | 2017-11-10 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002067104 | SCV002456972 | likely benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2023-06-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002369993 | SCV002686759 | uncertain significance | Cardiovascular phenotype | 2022-07-14 | criteria provided, single submitter | clinical testing | The c.9330T>A variant (also known as p.V3110V), located in coding exon 38 of the TTN gene, results from a T to A substitution at nucleotide position 9330. This nucleotide substitution does not change the valine at codon 3110. This nucleotide position is not well conserved in available vertebrate species. In silico splice site analysis predicts that this alteration will result in the creation or strengthening of a novel splice donor site. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |